Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant a » significant _ (Expand Search), significant gap (Expand Search), significant all (Expand Search)
significant i » significant _ (Expand Search), significant co (Expand Search), significant 17 (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 1,221 - 1,240 results of 21,342 for search '(( significant decrease decrease ) OR ((( significant a decrease ) OR ( significant i decrease ))))', query time: 0.78s Refine Results
  1. 1221
    Patient Demographics.

    Patient Demographics. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1222
    Diagnostic Criteria for Human Disharmony Loop.

    Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1223
    The Human Disharmony Loop Clinical Presentation.

    The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1224
    BPCA ratios and proxies evaluated in this study. The variable <i>n</i> in the equation for the Average CAS refers to the number of carboxylic acid substitutions (3, 4, 5 or 6). The “expected correlations” column details the trends anticipated for the values yielded by the ratio or proxy as a function of pyrolysis temperature, with implications for aromaticity and aromatic condensation. For instance, with hotter pyrolysis temperatures (red arrow), the average CAS should increase. This is indicative of increased aromaticity (“+ arom”) and increased aromatic condensation (“+ cond”). Blue arrows indicate decreasing or cooler pyrolysis temperatures.<b> </b><i> </i>

    BPCA ratios and proxies evaluated in this study. The variable <i>n</i> in the equation for the Average CAS refers to the number of carboxylic acid substitutions (3, 4, 5 or 6). The... by Ivy Notterpek (21368133)

    Published 2025
    Save to List
    Saved in:
  5. 1225
    S1 File -

    S1 File - by Ruiming Xiao (6389546)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 1226
    Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It includes the number of participants in each group, frequency, intensity, and duration of chills, along with demographics such as gender, age, race, education level, and income. Statistical significance (p-value) is also provided for each category.

    Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It... by Felix Alexandre Schoeller (20988295)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1227
    S1 Data -

    S1 Data - by Du Siqi (20721422)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1228
    S1 File -

    S1 File - by Du Siqi (20721422)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1229
    RipE1 interacts with NbUCH12 and NbUCH15.

    RipE1 interacts with NbUCH12 and NbUCH15. by Wenjia Yu (9422059)

    Published 2025
    Save to List
    Saved in:
  10. 1230
    Annual number of outpatient visits in recurrence and non-recurrence groups.

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1231
    Annual treatment frequencies in recurrence and non-recurrence groups.

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1232
    Time course of central retinal thickness (CRT) in all eyes.

    Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1233
    NbUCH15 promotes RipE1 stability by deubiquitination.

    NbUCH15 promotes RipE1 stability by deubiquitination. by Wenjia Yu (9422059)

    Published 2025
    Save to List
    Saved in:
  14. 1234
    Time course of best-corrected visual acuity (BCVA) in all eyes.

    Time course of best-corrected visual acuity (BCVA) in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1235
    Annual number of outpatient visits in all eyes.

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1236
    Annual treatment frequencies in all eyes.

    Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1237
    Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.

    Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1238
    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1239
    Surface 3D topography (a) UT, (b) SP1, (c) SP2, (d) SP3.

    Surface 3D topography (a) UT, (b) SP1, (c) SP2, (d) SP3. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1240
    Friction coefficients of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3.

    Friction coefficients of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: